KhabarAdda
Aggregated from Times of India, NDTV, Hindustan Times, India Today and more · Every source linked and credited · Updated every 15 minutes
Supreme Court to hear plea on EC’s Form 6 clarification amid concerns over Delhi voter roll revision‘Dynamic, talented young man’: Rahul Gandhi recalls Sidhu Moosewala’s Congress entry, meets singer’s fatherAgniveers’ tenure extended by two years, cabinet approves moveAAP alleges AQI data manipulation in Delhi, seeks legal action against CM Rekha Gupta, Sirsa‘Walked into room with tattoos’: Rahul recalls first meeting with Sidhu MoosewalaKohli’s 74, Arshdeep’s 4-wicket haul guide India to victory against New ZealandKing Charles sold racehorse months before it won Melbourne Cup in sixth start“An Abdul Has Won In Michigan”: Asaduddin Owaisi’s UP Pitch After US Senate RaceGuwahati Hotel Shoot Out Accused Dies In Encounter While Trying To EscapeIn Republicans’ Mega Loss In US Midterms, A Possible Win For Ukraine
Markets

Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October

vialivemint.com7 Oct
Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October
Sun Pharmaceutical Industries will hold a Board meeting on October 12, 2026, to approve the issuance of non-convertible debentures worth up to ₹15,000 crore to fund a bridge loan for acquiring Organon & Co.

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to livemint.com's own reporting rather than reproducing it — the excerpt above comes from livemint.com's own feed.

Read the full story on livemint.com ↗